Occurrence of Pancreatic Exocrine Insufficiency in Patients with Advanced Neuroendocrine Tumours Treated with Somatostatin Analogue

被引：0
|
作者：
De Felice, I [1 ]
Rinzivillo, M. [1 ]
Pratesi, M. S. [1 ]
Magi, L. [1 ]
Annibale, B. [2 ]
Panzuto, F. [1 ]
机构：
[1] St Andrea Univ Hosp, ENETS Ctr Excellence, Digest Dis Unit, Rome, Italy
[2] Sapienza Univ Rome, Dept Med Surg Sci & Translat Med, Rome, Italy
来源：
NEUROENDOCRINOLOGY | 2020年 / 110卷
关键词：
pancreatic exocrine insufficiency;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H09
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [41] Retrospective evaluation of success and survival in dogs treated for exocrine pancreatic insufficiency
    Roth, Nadine
    Neiger, Reto
    KLEINTIERPRAXIS, 2011, 56 (03): : 117 - 121
  • [42] Subclinical Exocrine Pancreatic Insufficiency Is a Disease That can Be Identified and Should Be Treated
    Van Thiel, David H.
    George, Magdalena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1450 - S1451
  • [43] Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis
    Iglesia, Daniel de la
    Avci, Bartu
    Kiriukova, Mariia
    Panic, Nikola
    Bozhychko, Maryana
    Sandru, Vasile
    de-Madaria, Enrique
    Capurso, Gabriele
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (09) : 1115 - 1125
  • [44] Pancreatic Exocrine Insufficiency in Intraductal Papillary Mucinous Carcinoma Presenting with Leg Edema Treated with Pancreatic Exocrine Replacement Therapy
    Tanaka, Emi
    Ogawa, Tsuneyoshi
    Tsutsumi, Koichiro
    Kobayashi, Sayo
    Nawa, Toru
    Ueki, Toru
    Okada, Hiroyuki
    INTERNAL MEDICINE, 2022, 61 (13) : 1963 - 1967
  • [45] ECONOMIC IMPACT OF TREATMENT ADHERENCE IN EXOCRINE PANCREATIC INSUFFICIENCY (EPI) PATIENTS TREATED WITH PANCREATIC ENZYME REPLACEMENT THERAPY (PERT)
    Khandelwal, N.
    Wang, S.
    Johns, B.
    Vora, J.
    Castelli-Haley, J.
    Singh, V. K.
    VALUE IN HEALTH, 2018, 21 : S85 - S86
  • [46] The impact of metformin on progression-free survival in patients with advanced pancreatic well differentiated neuroendocrine tumor receiving everolimus plus somatostatin analogue treatment
    Pusceddu, Sara
    Buzzoni, Roberto
    Concas, Laura
    Bregant, Cristina
    Leuzzi, Livia
    Milione, Massimo
    Seregni, Ettore
    Formisano, Barbara
    Consonni, Paola
    De Braud, Filippo
    CANCER RESEARCH, 2015, 75
  • [47] Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency
    Klassen, Pamela N.
    Mazurak, Vera C.
    Baracos, Vickie
    Martin, Lisa
    Ghosh, Sunita
    Kasnik, Jessica
    Sawyer, Michael B.
    CLINICAL NUTRITION, 2024, 43 (08) : 1900 - 1906
  • [48] Pancreatic exocrine insufficiency (PI) secondary to chronic use of long-acting (LA) somatostatin analogues (SA) in patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Saif, Wasif M.
    Smith, Melissa H.
    Romano, Alicia
    Patel, Rachna
    Relias, Valerie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [49] Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus
    Vujasinovic, Miroslav
    Zaletel, Jelka
    Tepes, Bojan
    Popic, Betka
    Makuc, Jana
    Lenart, Metka Epsek
    Predikaka, Marjana
    Rudolf, Sasa
    PANCREATOLOGY, 2013, 13 (04) : 343 - 346
  • [50] Incidence of Pancreatic Exocrine Insufficiency in Patients Undergoing Liver Transplantation
    Klein, J.
    Rangel, M.
    Ifearulundu, I.
    Gely, Y.
    Spigel, Z.
    Janardhan, S.
    Hertl, M.
    Chan, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 574 - 575
12345